Ardsley Advisory Partners’s Elevance Health ELV Stock Holding History

Ardsley Advisory Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-70,000	Closed	-$19.8M	–	149
2019 Q2	$19.8M	Buy	+70,000	New	+$19.1M	3.12%	9
2018 Q4	–	Sell	-170,000	Closed	-$46.6M	–	114
2018 Q3	$46.6M	Buy	170,000 +130,000	+325%	+$33.7M	6.28%	2
2018 Q2	$9.52M	Buy	+40,000	New	+$9.26M	1.43%	25

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Ardsley Advisory Partners's ELV Position: Q3 2019 in Review

Ardsley Advisory Partners sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 94,500 shares — an estimated $26.7M sold.

Ardsley Advisory Partners first reported a position in ELV in Q1 2018 and held it in 6 quarters. The position peaked at $26.7M in Q2 2019. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

Ardsley Advisory Partners reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
Ardsley Advisory Partners sold 94,500 Elevance Health shares in Q3 2019, an estimated $26.7M.
Ardsley Advisory Partners first reported a position in Elevance Health in Q1 2018 and held it in 6 quarters.
Ardsley Advisory Partners's Elevance Health position peaked at $26.7M in Q2 2019.
1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Ardsley Advisory Partners's 13F filing for Q3 2019, filed 14 Nov 2019.